E-Paper
China’s Sinovac secures $500 million in funding for Covid-19 vaccine development
In a statement on its website, the company said it expects to be able to manufacture 300 million vaccine doses annually, and that it aims to complete construction of a second production facility by the end of 2020 to increase annual Covid-19 vaccine production capacity to 600 million doses.
Updated on: Dec 7, 2020, 06:23:30 IST
Share via
Copy link
China’s Sinovac Biotech said on Monday that it had secured approximately $500 million in funding for Covid-19 vaccine development.
In a statement on its website, the company said it expects to be able to manufacture 300 million vaccine doses annually, and that it aims to complete construction of a second production facility by the end of 2020 to increase annual Covid-19 vaccine production capacity to 600 million doses.
Sinovac said the investor is Sino Biopharmaceutical Ltd.
Get the latest World News, breaking headlines and global updates from the US, UK, Pakistan, Bangladesh, Russia and other countries. Follow major international events on Hindustan Times.
